Most Insurances Accepted!
Call Ardu Recovery Center Today
Written by Drew Redd. Mina Draskovic, B.Psy., reviewed this content for accuracy.
Benzodiazepine tapering is a medical process of gradually reducing medication doses to prevent dangerous withdrawal effects. These medications are often prescribed for anxiety and sleep disorders, but stopping their use requires professional supervision.
An online Finlayson survey (2022) revealed that 95% of benzodiazepine users need medical supervision to discontinue their medication safely. The effects of stopping benzodiazepines go beyond physical withdrawal symptoms; most people experience serious disruptions to their work and relationships, while over half report having suicidal thoughts.
Our experienced medical team provides comprehensive medication reduction plan services with 24/7 clinical support. Contact our benzodiazepine detox center to get started.
Benzodiazepines are medications commonly prescribed for anxiety, severe panic attacks, insomnia, and seizures. The U.S. Food and Drug Administration (FDA) indicates that over 92 million prescriptions are written annually in the United States.
Among all benzodiazepine prescription drugs, the most common ones are:
These medications are effective for short-term use (2–4 weeks), but even when taken exactly as prescribed, long-term use can lead to physical dependence and benzodiazepine addiction. About half of the patients who take benzodiazepines for two months or longer experience withdrawal complications when they quit.
According to a comprehensive 2022 online study, 95% of benzodiazepine users need medical supervision to quit because sudden discontinuation can cause intense withdrawal symptoms including:
The study also explains that a small percentage (about 5%) of patients were able to stop without problems, but most people need a carefully structured tapering plan that can take months or even years.
If you or someone you care about is struggling with a benzo addiction, help is available. Ardu’s specialized benzodiazepine rehab program integrates clinical expertise with individualized tapering schedules, constant monitoring, and therapeutic tools to address the unique challenges of benzodiazepine withdrawal.
Benzodiazepine tapering is a complex medical process often guided by the principles of the Ashton Method, a widely recommended approach for safe and effective dose reduction. This method involves transitioning to a longer-acting benzodiazepine, such as diazepam, and gradually decreasing doses to minimize withdrawal symptoms and support recovery.
A safe and successful benzodiazepine taper should follow these steps:
Many people struggling with benzodiazepine dependence originally started taking them to cope with anxiety, depression, or other mental health conditions. At Ardu, we tackle both issues at the same time.
Our dual diagnosis program targets benzodiazepine tapering and mental health treatment through integrated psychiatric care and evidence-based therapies. We work closely with you to identify and treat underlying conditions while supporting your taper, so you can build sustainable alternatives to benzodiazepine use.
Reach out to Ardu, and take the first step toward freedom from prescription medication dependence.
Benzodiazepine tapering can be dangerous when done abruptly or without medical supervision. A 2006 study found that most patients who are getting off of benzodiazepines report relatively mild effects such as insomnia (20.5%), anxiety (15%), and irritability (13.6% of patients). However, this study excluded these high-risk patient groups:
These high-risk individuals face increased dangers of severe withdrawal complications. For them, specialized medical supervision, comprehensive monitoring, and carefully structured tapering protocols are necessary.
Our drug detox services include specialized benzodiazepine tapering programs with 24/7 medical monitoring, customized benzo taper schedules, and board-certified physicians who guide you safely through each step of your recovery process.
The data shows that professional medical support significantly improves success rates in benzodiazepine tapering. A 2018 study conducted in the Netherlands offers insights into the effectiveness of a structured tapering program. 62% of patients successfully discontinued benzodiazepines under medical supervision.
According to a Spanish clinical trial, patients who received structured medical support and tapering schedules were five times more likely to successfully discontinue benzodiazepines than those who didn’t. 45.2% of the intervention group successfully quit within 12 months, while only 9.1% of the control group managed to stop without structured support. Another 21.9% of patients in the medically supervised group achieved at least a 50% reduction in their benzodiazepine dose.
Most doctors start with a moderate decrease, about 25% of your current dose, during the first two weeks to see how your body responds. After that, the reductions become smaller, usually 10–15% every couple of weeks. As you reach lower doses, your body becomes more sensitive to changes, so the decreases become even more gradual—around 5% every 2–4 weeks.
For example, if you’re taking 2 milligrams of Xanax daily, your doctor might first reduce it to 1.5 mg for two weeks. If you handle that well, you’d move to 1.25 mg for the next two weeks, then to 1 mg, and so on. When you get down to smaller amounts, such as 0.5 mg, the reductions become very subtle, sometimes just tiny adjustments every few weeks to keep you comfortable and stable.
Many treatment plans involve switching to a longer-acting benzodiazepine first, which can help make the process smoother since the medication leaves your system more gradually. Longer-acting benzodiazepines such as Valium remain in your system for 20–100 hours (compared to just 6–12 hours for short-acting benzodiazepines such as Xanax). This makes withdrawal more manageable. Doctors often switch patients to these longer-acting medications during tapering because their gradual elimination maintains steady blood levels and allows for more precise dose reductions.
At Ardu rehab facility, we use precise measurements and carefully monitor your progress to adjust these reductions based on how you’re feeling at each step.
We employ evidence-based protocols for safe benzodiazepine tapering under constant medical supervision. As an integral part of our drug rehab treatment center, our board-certified physicians create personalized reduction schedules based on your specific situation. Our approach combines precise medical management with therapeutic support to help you safely overcome benzodiazepine dependence and regain your quality of life.
Our tapering program includes:
Beyond our evidence-based medical protocols, we integrate a range of holistic detox therapies to address the physical and emotional aspects of benzodiazepine withdrawal for complete healing and lasting wellness.
Our holistic therapies complement your medical treatment and ease withdrawal symptoms naturally. This integrative approach combines traditional healing practices with modern wellness techniques to support your body and mind throughout the recovery process.
Our holistic services include:
Our treatment providers will work closely with you to develop a personalized recovery plan that meets your unique needs during the detox process and beyond. Visit our admissions process page, and contact our admissions team for more information.
Reach out to Ardu Recovery Center today to learn more about our personalized treatment options, and let us help you build a brighter tomorrow.
Drew Redd is the executive director of Ardu Recovery Center and is dedicated to empowering people on their journey to sobriety.
The withdrawal timeline depends on your current dose, medication type, and individual factors. With medical detox supervision, gradual dose reduction typically takes 6–12 months, though some require up to 18 months for safe discontinuation of benzodiazepines.
Short-acting benzos produce more intense initial withdrawal effects that peak earlier, while long-acting benzodiazepines allow for a smoother withdrawal process. Under proper medical supervision, withdrawal symptoms can be managed through careful dose reduction schedules. The first phase typically involves the initial reduction of 25% from the current dose, followed by smaller, incremental decreases based on patient response and withdrawal effects.
Long-acting benzodiazepines, particularly diazepam (Valium), are easier to withdraw from because of their gradual elimination from the body. During medical detox, doctors often switch patients from short-acting benzos to long-acting ones to facilitate easier dose reduction and minimize withdrawal effects. The current dose can be reduced more smoothly with these medications because they maintain more stable blood levels.
This approach, supported by extensive research on long-term benzodiazepine use, helps prevent severe withdrawal symptoms that often occur with short-acting benzos. Medical supervision ensures proper conversion between medications and careful monitoring of withdrawal effects throughout the tapering process.
Benzo belly is a common withdrawal effect experienced during dose reduction from long-term benzodiazepine use. This condition involves gastrointestinal symptoms including bloating, nausea, cramping, and digestive issues that can persist throughout the medical detox process. The severity often correlates with your current dose and speed of reduction. Medical supervision manages these withdrawal effects through proper tapering schedules and effective treatments. While uncomfortable, these symptoms typically improve as the body adjusts to each dose reduction.
Reverse tolerance in long-term benzodiazepine use occurs when patients become increasingly sensitive to their current dose, so they require dose reduction rather than escalation. This paradoxical reaction can complicate the withdrawal process and intensify withdrawal effects. This phenomenon often indicates neuroadaptation from long-term benzodiazepine use and requires careful medical supervision during dose reduction.
During medical detox and dose reduction from long-term benzodiazepine use, dietary choices impact gastrointestinal withdrawal effects. Anti-inflammatory foods, easily digestible proteins, and nutrient-rich vegetables help support digestive health during tapering. Avoid inflammatory foods, caffeine, and processed sugars to reduce symptoms.
Healthcare providers may recommend specific dietary protocols based on your current dose and benzo withdrawal symptoms, incorporating foods that support gut healing and reduce inflammation during benzodiazepine discontinuation.
Benzodiazepines negatively impact several organs, especially with long-term use or during withdrawal. Their effects extend beyond calming the central nervous system and influence other vital systems in the body. Here’s how they affect specific organs and systems:
The Ashton Method is a widely recognized benzodiazepine taper schedule designed for safe discontinuation, particularly after long-term use. Developed by Professor Heather Ashton, the protocol involves switching to a long-acting benzodiazepine, such as diazepam, to stabilize withdrawal symptoms before initiating gradual dose reduction. It recommends reducing daily doses by 5–10% every 2–4 weeks, allowing the body to adjust over an extended period.
The Ashton Method emphasizes flexibility, as healthcare providers tailor the tapering process based on individual withdrawal effects, such as rebound anxiety, muscle spasms, or risk of seizures. This approach prioritizes patient safety by aligning each dose reduction with their response, minimizing adverse effects, and keeping you on the road to recovery.
Reid Finlayson, A. J., Macoubrie, J., Huff, C., Foster, D. E., & Martin, P. R. (2022). Experiences with benzodiazepine use, tapering, and discontinuation: An Internet survey. Therapeutic Advances in Psychopharmacology, 12, 20451253221082386. https://doi.org/10.1177/20451253221082386
Vicens, C., Fiol, F., Llobera, J., Campoamor, F., Mateu, C., Alegret, S., & Socías, I. (2006). Withdrawal from long-term benzodiazepine use: Randomised trial in family practice. The British Journal of General Practice, 56(533), 958. https://pmc.ncbi.nlm.nih.gov/articles/PMC1934057/
Voshaar, R. C. O., Gorgels, W. J. M. J., Mol, A. J. J., Van Balkom, A. J. L. M., Van De Lisdonk, E. H., Breteler, M. H. M., Van Den Hoogen, J. M., & Zitman, F. G. (2003). Tapering off long-term benzodiazepine use with or without group cognitive-behavioural therapy: three-condition, randomised controlled trial. The British Journal of Psychiatry, 182(6), 498–504. https://doi.org/10.1192/bjp.182.6.498
The basis of Ardu’s cognitive-behavior therapy
Ardu’s dual diagnosis treatments for PTSD
Why is the risk of relapse with addicts so high?
Can drug withdrawal cause severe symptoms?
Specialized detox program for men
